Dose-finding and -Expansion Studies of Trastuzumab Deruxtecan in Combination with Other Anti-Cancer Agents in Patients (pts) with Advanced/metastatic HER2+(DESTINY-Breast07 [DB-07]) and HER2-low (Destiny-Breast08 [DB-08]) Breast Cancer (BC)
JOURNAL OF CLINICAL ONCOLOGY（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined